Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

Share Price Information for Biome Tech (BIOM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 82.50
Bid: 75.00
Ask: 90.00
Change: -17.50 (-17.50%)
Spread: 15.00 (20.00%)
Open: 87.50
High: 82.50
Low: 76.00
Prev. Close: 100.00
BIOM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

24 Jul 2014 15:28

RNS Number : 2704N
Biome Technologies PLC
24 July 2014
 



 

24 July 2014

Biome Technologies plc

 ("Biome", "the Company" or "the Group")

 

Trading Update

 

 

Biome Technologies plc, a leading bioplastics and radio frequency technology business, today publishes a trading update, ahead of its interim results for the six-month period ended 30 June 2014, which are expected to be announced on 3 September 2014.

 

Trading Update

 

Total Group revenues achieved for the second quarter of 2014 were £1.2m (Q1 2014: £1.1m; Q2 2013: £0.5m). The turnover for the second quarter maintains the significant progress made in the first quarter of 2014 compared to the same period in the prior year and means that revenues generated by the Group in the first half of 2014 at £2.3m are now in excess of those for the full year of 2013.

 

The Group's cash position at 30 June 2014 was £3.1m (31 March 2014: £3.2m).

 

The business continues to make good progress with the strategy to commercialise and develop wholly owned intellectual property. Performance in the first half was ahead of the Board's expectations for both divisions.

 

Bioplastics Division

 

Q2 2014 revenues for the Bioplastics Division were £0.6m (Q1 2014: £0.5m; Q2 2013: £0.1m) 21% ahead of Q1 2014 performance. Revenues generated by the Bioplastics Division in the first half of 2014 were therefore £1.1m, already in excess of the £1.0m full year 2013 revenue.

 

The focus of the division on developing high margin, application led bioplastic polymers with enhanced level of functionality is starting to take hold. Increasing volumes of Biome's materials were procured in the period for use in the US single-serve coffee market amongst other applications. Further progress was made in the development of the pipeline of new products with technical and customer trials continuing in both the food service and paper-board coating sectors.

 

The division announced the successful completion of a feasibility study undertaken in conjunction with the University of Warwick's Centre for Biotechnology and Biorefining and supported by the Government-backed Technology Strategy Board (TSB).

 

Stanelco RF Technologies Division

 

Q2 2014 revenues for the RF Division were £0.6m (Q1 2014: £0.6m; Q2 2013: £0.4m) maintaining the promising start that the division made in the first quarter of the year. Revenues for the first half of 2014 were £1.2m and are now in excess of the revenues achieved by this division for the full year 2013.

 

Activity and ordering levels in the first half have been encouraging with some evidence that the market for fibre optic furnaces, one of the main repeating products for the division, is experiencing some recovery in Asia. The contract with a customer from a regulated industry has commenced and receipts of approximately one quarter of contract value were received during the first half of 2014. Enquiry and order levels for the business are robust.

 

Group Outlook

 

The Group's revenues and cash are slightly ahead of the Board's expectations at the mid-year point with the reporting of the interim results scheduled for 3 September 2014.

 

This has been a positive first half for the Group and the Board is confident that this progress can be maintained for the full year.

 

-Ends-

 

 

For further information please contact:

 

Biome Technologies plc

Paul Mines, Chief Executive Officer

Declan Brown, Group Finance Director

www.biometechnologiesplc.com

Tel: +44 (0) 2380 867 100

Daniel Stewart & Company plc

David Hart (Nominated Adviser)

Mark Treharne (Broker)

www.danielstewart.co.uk

Tel: +44 (0) 20 7776 6550

Allenby Capital

Chris Crawford/Kelly Gardiner

www.allenbycapital.com

Tel: +44 (0) 20 3002 2070

FTI Consulting

Oliver Winters

www.fticonsulting.com

Tel: +44 (0) 20 3727 1535

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTQKQDBQBKDOOB
Date   Source Headline
16th Oct 20063:17 pmRNSNotifiable Interest
12th Oct 200612:35 pmRNSDoc re. Posting of Prospectus
11th Oct 20061:09 pmRNSNotifiable Interest
9th Oct 200611:13 amRNSProposed Placing & Open Offer
5th Oct 200610:25 amRNSFinancing Update
3rd Oct 200612:56 pmRNSStatement re. Press Comment
2nd Oct 20064:41 pmRNSSecond Price Monitoring Extn
2nd Oct 20064:35 pmRNSPrice Monitoring Extension
8th Sep 20067:01 amRNSTrading Statement
17th Aug 20067:44 amRNSTrading Statement
16th Aug 20065:52 pmRNSAdditional Listing - AMEND
14th Aug 200611:55 amRNSAdditional Listing
10th Aug 200612:25 pmRNSRe Contract
14th Jul 20067:56 amRNSInterim Results - Replacement
14th Jul 20067:00 amRNSInterim Results
2nd Jun 200611:26 amRNSNew Ord Share Placing-Amendmt
2nd Jun 20068:45 amRNSNew Ordinary Share Placing
25th May 20067:02 amRNSWrap 100 FDA approval
16th May 200610:43 amRNSAdditional Listing
15th May 20067:01 amRNSAppointment of Adviser
3rd May 20061:05 pmRNSNotifiable Interest
2nd May 20064:58 pmRNSResult of AGM
2nd May 20062:00 pmRNSAGM Statement
10th Apr 20063:12 pmRNSAnnual Report and Accounts
7th Apr 20062:46 pmRNSAdditional Listing
13th Mar 20067:02 amRNSDirectorate Change
28th Feb 20067:02 amRNSPreliminary Results
24th Feb 20067:02 amRNSCooperation with Wal-Mart
14th Feb 20069:07 amRNSAdditional Listing
14th Feb 20067:00 amRNSUS FDA approval for Starpol
9th Feb 200610:42 amRNSIsraCaps new licence terms
9th Feb 20067:02 amRNSRe: BioProgress plc
16th Dec 20057:01 amRNSFunding for R&D facility
16th Dec 20057:01 amRNSPre Close Update
14th Dec 20057:01 amRNSLandmark deal with Perseco
8th Dec 200510:25 amRNSShare Listing Application
30th Nov 20055:40 pmRNSDirectorate Change
28th Nov 20059:24 amRNSBoard Changes
8th Nov 20057:01 amRNSPatent sale process update
3rd Nov 20054:47 pmRNSExercise of Options
1st Nov 20057:02 amRNSChange of Adviser
12th Oct 20057:00 amRNSApproval of Starpol
3rd Oct 20057:00 amRNSPatent Disposal & Update
22nd Sep 20057:02 amRNSRe Agreement
12th Sep 20057:03 amRNSDevelopment of capsule
5th Sep 20057:03 amRNSRe: Completion
30th Aug 20053:30 pmRNSDoc re. Result of EGM
30th Aug 200511:08 amRNSEGM Statement
30th Aug 20057:03 amRNSRe Agreement
5th Aug 200511:15 amRNSRe posting of circular

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.